Novo Nordisk Stock Decline - Search News

Order byBest matchMost fresh

News

CEO of Novo Nordisk, maker of weight loss drug Wegovy

Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.

Continue reading

· 4d · on MSN

Novo Nordisk Boots CEO After Stock Falls 50%. It’s an Unusual Move for the Wegovy Drugmaker.

· 4d · on MSN

Novo Nordisk CEO steps down as Wegovy maker faces increased competition

4d

Ozempic-Maker CEO Ousted Over Pharma Company’s Rocky Market Downturn

In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...

5d

Ignore The Noise - Novo Nordisk Is A Clear Buy

Novo Nordisk's current product portfolio is well-protected by patents until at least 2030. Click here to see why NVO stock is ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results